Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01419730 · ClinicalTrials.gov registry record · Phase 2
Vitamin D and Physical Activity on Bone Health
A Phase 2 study of Physical Fitness and Bone Mineral Density, sponsored by University of Rochester.
- Active
- Registry status
- Phase 2
- Development phase
- 191
- Enrollment target
- 1
- Study location
NCT01419730: Active Phase 2 study of Physical Fitness and Bone Mineral Density, sponsored by University of Rochester.
NCT01419730 is a Phase 2 study of Physical Fitness and Bone Mineral Density that is active but no longer recruiting, run by University of Rochester. The registered enrollment target is 191 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01419730, a Phase 2 study of Physical Fitness and Bone Mineral Density, is active but no longer recruiting, sponsored by University of Rochester.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 191 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will examine the effectiveness of vitamin D or placebo (the placebo is a tablet that looks like Vitamin D study drug, but has no Vitamin D study drug in it), with and without physical activity (walking and progressive resistance exercise), in treating bone loss in women who have undergone treatment for breast cancer. The investigators would also like to find out if the physical activity program improves cardiovascular fitness, energy expenditure, muscular strength, muscle mass, and balance. One hundred five (105) subjects are expected to take part in this study. The investigators don't know if bone loss in breast cancer survivors should be treated differently than bone loss in other women.
Primary Outcome
To collect preliminary data on the effects of vitamin D therapy and exercise (alone or in combination) on bone mineral density (BMD) as measured by a dual energy X-ray absorptiometry (DXA) in non-metastatic breast cancer patients who began hormonal therapy within the previous 12 months. Amount of bone loss was measured with change in BMD.
Conditions Studied
Interventions
- BEHAVIORAL Physical Activity
- DRUG Vitamin D3
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2011-08 |
| Est. Completion | 2025-12-30 |
| Phase | Phase 2 |
What the registry record for NCT01419730 still lists
NCT01419730 is an interventional study that assigns participants to a tested intervention. The registered 191 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% higher).
The record links to 3 conditions, with Physical Fitness appearing as the primary indexed condition, and to 2 interventions - of which Physical Activity is the first listed.
NCT01419730 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01419730 about?
NCT01419730 is a clinical study titled "Vitamin D and Physical Activity on Bone Health". This research will examine the effectiveness of vitamin D or placebo (the placebo is a tablet that looks like Vitamin D study drug, but has no Vitamin D study drug in it), with and without physical activity (walking and progressive resistance exercise), in treating bone loss in women who have underg...
What is the current status of trial NCT01419730?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 191 participants. The study started on 2011-08. Estimated completion is 2025-12-30.
What conditions does trial NCT01419730 study?
This clinical trial studies the following conditions: Physical Fitness, Bone Mineral Density, Bone Metabolism Biomarkers.
What interventions are being tested in trial NCT01419730?
The interventions under investigation include: Physical Activity (BEHAVIORAL), Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT01419730?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01419730 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Fitness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01419730's enrollment target sits among peer trials
191 353rd of 2000 higher than 1,648 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04621435 · 191 participants · Phase 1
Imaging of Solid Tumors Using FAP-2286
- NCT06810544 · 191 participants · Phase 1
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia